Technology transfer / Localization · MENA · Announced 16 Jun 2026

Egyptian Ministry of Health and Population / Egyptian Drug Authority → International partners

At Africa Health ExCon 2026 in Egypt, the health ministry and drug authority oversaw several strategic partnerships on technology transfer and local manufacturing of vaccines and sera; partners were not named.

Parties: Egyptian Ministry of Health and Population / Egyptian Drug Authority (Egypt) → International partners (not named)

Value
Undisclosed
Territory
Egypt and Africa
Therapeutic area
Vaccines
Asset
Vaccines and sera (not named)
Announced
16 Jun 2026

Our analysis

Why this matters

During the fifth Africa Health ExCon (June 2026), Egypt's Ministry of Health and Population and the Egyptian Drug Authority oversaw the signing of several strategic partnerships on technology transfer and vaccine manufacturing, plus research, analytical support and clinical studies. The stated aim is to localise vaccine and biological-product manufacturing in Egypt and across Africa. Reports describe three agreements with national and international institutions in vaccines, pharmaceuticals, regenerative medicine and biomedical research, but name no counterparties, products, values or timelines.

Health Minister Khaled Abdel Ghaffar attended, with the chairs of the drug authority and the Unified Procurement Authority and representatives of WHO and Africa CDC.

The full analysis is free to read with a work email on this page.

Source: Egyptian Drug Authority

Latest deals

All MENA deals → · All technology transfer / localization deals → · Browse all emerging-market pharma deals →